Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Medicinas Complementárias
Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Dev Neurosci ; 76: 1-5, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31125683

RESUMEN

One of the reasons for using paracetamol during pregnancy is fever. The brain structure responsible for maintaining proper body temperature, but also for controlling some endocrine aspects is hypothalamus. In this study we examined the effect of early pretreatment of paracetamol on hypothalamic neurotransmission in rats' offspring. We used two-month old rats previously exposed to paracetamol at doses of 5 (P5) and 15 mg/kg (P15) during gestational development and next postnatally. The concentration of monoamines, their metabolites and amino acids in hypothalamus was chromatographically determined. The results of biochemical analysis were compared with the Control animals (Con). We found differences between groups in the concentration of main noradrenaline metabolite in hypothalamus. The control group had significantly higher level of 3-methoxy-4-hydroxyphenylglycol (MHPG) compared with rats exposed to paracetamol (F(2,27) = 7.96, p < 0.005). Simultaneously the level of dopamine (DA) (F(2,27) = 4.33, p < 0.05) and its metabolite - homovanillic acid (HVA) (F(2,27) = 17.03, p < 0.005) was increased in the hypothalamus of animals treated with lower dose of the drug. Biochemical analyses show an increase in 3,4-dihydroxyphenyl acetic acid (DOPAC) concentration in P5 group compared to the control rats and group treated with higher dose of paracetamol (F(2,27) = 7.37, p < 0.005). In the hypothalamus significant decrease of glutamic acid concentration was also observed in the group treated with paracetamol at dose of 5 mg. These results demonstrated that paracetamol had a significant effect on dopaminergic and noradrenergic neurotransmission and changed the concentration of glutamic acid in hypothalamus - heat-regulating center and important element of hypothalamic-pituitary- gonadal axis.


Asunto(s)
Acetaminofén/toxicidad , Analgésicos no Narcóticos/toxicidad , Hipotálamo/efectos de los fármacos , Hipotálamo/crecimiento & desarrollo , Ácido 3,4-Dihidroxifenilacético/metabolismo , Aminoácidos/metabolismo , Animales , Animales Recién Nacidos , Química Encefálica/efectos de los fármacos , Dopamina/metabolismo , Femenino , Glutamatos/metabolismo , Ácido Homovanílico/metabolismo , Hipotálamo/metabolismo , Masculino , Metoxihidroxifenilglicol/metabolismo , Norepinefrina/metabolismo , Embarazo , Ratas , Ratas Wistar , Transmisión Sináptica/efectos de los fármacos
2.
Phytother Res ; 30(5): 781-9, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26814055

RESUMEN

Passiflora incarnata L. has been used as a medicinal plant in South America and Europe since the 16th century. Previous pharmacological studies focused mainly on the plant's sedative, anxiolytic, and anticonvulsant effects on the central nervous system and its supporting role in the treatment of addiction. The aim of the present study was to evaluate the behavioral and neurochemical effects of long-term oral administration of P. incarnata. The passionflower extract (30, 100, or 300 mg/kg body weight/day) was given to 4-week-old male Wistar rats via their drinking water. Tests were conducted after 7 weeks of treatment. Spatial memory was assessed in a water maze, and the levels of amino acids, monoamines, and their metabolites were evaluated in select brain regions by high performance liquid chromatography (HPLC). We observed reduced anxiety and dose-dependent improvement of memory in rats given passionflower compared to the control group. In addition, hippocampal glutamic acid and cortical serotonin content were depleted, with increased levels of metabolites and increased turnover. Thus, our results partially confirmed the proposed mechanism of action of P. incarnata involving GABAA receptors. Copyright © 2016 John Wiley & Sons, Ltd.


Asunto(s)
Ansiolíticos/química , Anticonvulsivantes/química , Ansiedad/tratamiento farmacológico , Hipnóticos y Sedantes/uso terapéutico , Passiflora/química , Fitoterapia/métodos , Extractos Vegetales/química , Plantas Medicinales/química , Memoria Espacial/efectos de los fármacos , Transmisión Sináptica/efectos de los fármacos , Animales , Ansiolíticos/farmacología , Anticonvulsivantes/farmacología , Masculino , Extractos Vegetales/farmacología , Ratas , Ratas Wistar
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA